Research

Our research group have a profound interest in translational cancer research primarily within the field of hematological malignancies. We specialize in a comprehensive approach to cancer cell characterization all the way from basic laboratory molecular biology, tumor microenvironment description, large-scale proteomic studies, and imaging flow cytometry-based cell classification to investigation of novel gene-editing therapeutics. Collectively, we focus on combining these areas of expertise into the development of clinical applicable diagnostics and therapeutics for cancer patients with current unmet clinical needs.

Foundation

At the Department of Clinical Medicine, Aarhus University, and the Department of Hematology, Aarhus University Hospital, we have established a translational research environment where researchers and clinicians collaborate closely to enhance disease diagnostics and monitoring, as well as to investigate the biology of hematological malignancies. Our current research projects are founded on a robust base of knowledge and techniques developed by our research group and our close collaborators at the Department of Biomedicine, Aarhus University, and the Departments of Pathology, Pediatrics, and Oncology, Aarhus University Hospital. Our ongoing aim is to apply molecular biology to address clinical challenges.

Approach

We strive to foster an environment where engagement flourishes, driving cutting-edge research results. We believe that researchers' active involvement in every aspect of their projects is essential for fostering both engagement and enthusiasm. We cultivate a space where ideas can be easily generated and thoughtfully evaluated by providing a framework that is both reliable and flexible. This approach ensures that our researchers feel supported and motivated to make impactful contributions to the future of healthcare and, ultimately, to our society.